跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 159 条关于
“BioSight”
全部
159
临床试验
120
药物
9
机构
10
资讯
20
去年
Over 120 Pipeline Therapies Target Acute Myeloid Leukemia as Research Intensifies
去年
INSIGHT-003 Trial Completes Enrollment, Evaluating Efti Combination in Non-Small Cell Lung Cancer
2年前
mRNA Cancer Vaccines Show Promise in Personalized Immunotherapy
11个月前
Illumina Launches BioInsight AI Unit and Expands KRAS Companion Diagnostic Partnerships
3年前
Immutep's INSIGHT-003 Trial Reaches Enrollment Target in First-Line NSCLC
去年
NCFB Pipeline Shows Promise with Over 15 Companies Developing New Therapies
去年
Pompe Disease Pipeline Shows Promise with Novel Therapies in Development
去年
PROTACs: A Promising New Class of Targeted Protein Degraders Set to Revolutionize Disease Treatment
去年
T-Cell Lymphoma Pipeline Shows Promise with Novel Therapies and Regulatory Support
去年
Phage Therapies and Novel Molecules Show Promise in Treating Chronic Pseudomonas Aeruginosa Pulmonary Infections
第 1 页,共 2 页
上一页
下一页